NASS Preview: NASS Survey Finds Spine Professionals Independent and Influencing Decisions
In 2015, NASS conducted a survey taken by nearly 650 Members in the U.S. to support a clearer understanding of its Members practice settings. Aug 16, 2016
Developing New Orthopaedic Business Models: 2020 and Beyond
To thrive in the healthcare environment of tomorrow, orthopaedic device companies will need to operate within a greater portion of the supply chain, assisting upstream and downstream customers in finding operational value. This will require companies to forge stronger relationships, focus on internal efficiencies and launch services, not just devices. Jul 22, 2016
Wright’s Dedication to Extremities Strategies Brings Questions of What’s Next
Wright Medical's divestiture of its large joint portfolio to Corin Orthopaedics officially turns Wright into the extremities company that it set out to become years ago, and leads to the question: What's next in their M&A strategy? Jul 22, 2016
Arthroscopy/Soft Tissue Companies Address Meniscus, Rotator Cuff Repair
The arthroscopy/soft tissue segment reached sales of $4.5 billion in 2015, a four percent increase over 2014, according to ORTHOWORLD estimates. Growth in the market is buoyed by several factors: strength of the main players, smaller players expanding their portfolios to complement other product lines, industry focus and surgeon adoption of minimally invasive techniques and surgeons' push to drive new technologies and techniques in ligament and tendon care and repair. Apr 22, 2016
Bundled Payments: AAOS Conversations Center on CJR and Beyond
The advent of the Centers for Medicare & Medicaid's Comprehensive Care for Joint Replacement (CJR) program fueled AAOS Annual Meeting conversations regarding the best response by hospitals, surgeons and device companies to bundled payment reimbursement models, including those that extend beyond joint reconstruction. Mar 18, 2016
Anika Responds to CINGAL’s Drug Classification
In late 2015, FDA assigned Anika Therapeutics' CINGAL to the Center for Drug Evaluation and Research (CDER) and not the Center for Device and Radiological Health (CDRH) for its premarket review-a decision with which Anika's leadership says it disagrees. Jan 25, 2016
Bioventus Boosts Orthobiologics Business with Acquisitions
Bioventus spent most of 2015 building an infrastructure to expand its surgical business. With trecent acqusitions, a sales and distribution plan in place and future plans for inorganic and organic growth, Bioventus executives now say that the company is positioning itself as an orthobiologics leader. Jan 22, 2016
Spine Companies List Manufacturing Shifts Among Strategic Priorities
Alphatec Spine, Globus Medical and NuVasive announced updates to their manufacturing strategies earlier this year. The companies have taken different... Nov 01, 2015
Orthopaedic Investments Not Halted by China’s Challenged Economy
While China's stock market volatility has disrupted global markets and fueled fears of a sliding economy, current events haven't appreciably affected the country's healthcare market and shouldn’t deter medical device investors, according to industry leaders and consultants. Oct 01, 2015
Success in Orthopaedics Lies in Products that Improve Quality, Decrease Costs
Price pressure will continue to drive the orthopaedic industry's narrative in coming years as cost containment measures from public and private payors trickle through the healthcare supply chain. Executives at OMTEC 2015 offered key insight on overcoming industry's challenges. Jul 01, 2015
